BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29372346)

  • 1. Heavy Chain Disease of the Small Bowel.
    Bianchi G; Sohani AR
    Curr Gastroenterol Rep; 2018 Jan; 20(1):3. PubMed ID: 29372346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
    Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
    Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.
    Al-Saleem T; Al-Mondhiry H
    Blood; 2005 Mar; 105(6):2274-80. PubMed ID: 15542584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
    Shih LY; Liaw SJ; Dunn P; Kuo TT
    J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoproliferative small intestinal disease associated with Campylobacter jejuni.
    Lecuit M; Abachin E; Martin A; Poyart C; Pochart P; Suarez F; Bengoufa D; Feuillard J; Lavergne A; Gordon JI; Berche P; Guillevin L; Lortholary O
    N Engl J Med; 2004 Jan; 350(3):239-48. PubMed ID: 14724303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoproliferative small intestinal disease associated with Campylobacter jejuni.
    Mesnard B; De Vroey B; Maunoury V; Lecuit M
    Dig Liver Dis; 2012 Sep; 44(9):799-800. PubMed ID: 22552252
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoproliferative small intestinal disease: Mediterranean lymphoma and alpha heavy chain disease.
    Martin IG; Aldoori MI
    Br J Surg; 1994 Jan; 81(1):20-4. PubMed ID: 8313111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter coli cultured from the stools of a patient with immunoproliferative small intestinal disease.
    Coeuret S; de La Blanchardière A; Saguet-Rysanek V; Chèze S; Tavernier M; Arsène D; Criscuolo A; Brisse S; Vergnaud M; Verdon R; Lecuit M
    Clin Microbiol Infect; 2014 Sep; 20(9):908-11. PubMed ID: 24438451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
    Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
    World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
    Zahner J; Kirchner T; Ott G; Schneider W
    Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
    Nair S; Mathan M; Ramakrishna BS; Mathan VI
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time.
    AlYamany R; Kharfan-Dabaja MA; Hamadani M; Alshaibani A; Aljurf M
    Curr Oncol; 2022 May; 29(5):3759-3769. PubMed ID: 35621691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal malignancy and campylobacter jejuni.
    Peek RM
    Gastroenterology; 2004 Oct; 127(4):1266-7; discussion 1267-8. PubMed ID: 15481007
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
    Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
    Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoproliferative small intestinal disease (IPSID) in Thailand.
    Pramoolsinsap C; Kurathong S; Atichartakarn V; Nitiyanand P
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):11-7. PubMed ID: 8362283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoproliferative small intestinal disease: case report and literature review.
    Trotman BW; Pavlick AC; Igwegbe IC; Goldstein MM
    J Assoc Acad Minor Phys; 1999; 10(4):88-93. PubMed ID: 10826015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of laparotomy in immunoproliferative small intestinal disease.
    Tabbane F; Mourali N; Cammoun M; Najjar T
    Cancer; 1988 Apr; 61(8):1699-706. PubMed ID: 3349430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoproliferative small intestinal disease: prolonged 30-year course without development of lymphoma.
    Lin OS; Gray GM
    Am J Gastroenterol; 2001 Sep; 96(9):2769-74. PubMed ID: 11569710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoproliferative small intestinal disease: a study of 13 cases with alpha heavy-chain disease.
    Price SK
    Histopathology; 1990 Jul; 17(1):7-17. PubMed ID: 2227833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explosive Campylobacter jejuni diarrhea in immunoproliferative small intestinal disease.
    Puri AS; Aggarwal R; Khan EM; Naik S; Ayyagari A; Pandey R; Naik SR
    Indian J Gastroenterol; 1992 Jul; 11(3):141-3. PubMed ID: 1506053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.